赤血球の酸化窒素が内分泌血管調節剤としての作用: 充血性心不全における潜在的な役割
Borunendra Datta1, Timothy Tufnell-Barrett, Robert A Bleasdale
1Department of Cardiology, Wales Heart Research Institute, University of Wales College of Medicine, Heath Park, Cardiff, UK.
Circulation
|March 17, 2004
まとめ
赤血球は窒素酸化物 (NO) を放出し,低酸素状態で血管をリラックスさせます. このNO輸送メカニズムは,閉塞性心不全 (CHF) 患者において変化し,血流調節に影響を与えます.
科学分野:
- 生理学 生理学とは
- 心血管科学 心血管科学
- 呼吸器医学とは
背景:
- 酸化窒素 (NO) は,血管の調節に作用する.
- NOとヘモグロビンの間で形成される血管活性代謝物は,酸素化中に形成されます.
- 低酸素状態におけるこれらの代謝物の機能については,さらなる調査が必要である.
研究 の 目的:
- 低酸素血管拡張におけるNO-ヘモグロビン代謝物の役割を調査する.
- これらのメカニズムを,健康な個人および心不全 (CHF) 患者で調べる.
主な方法:
- 先行収縮した大動脈のリングと赤血球 (RBC) を用いた実験室内研究では,酸素の圧力が変化している.
- 健康な被験者およびCHF患者におけるNO代謝産物のトランスプルモナリー・グラデーションのイン・ビボ測定.
主要な成果:
- 赤血球は低酸素期における血管リラクゼーションを誘導し,周期性ガニリルモノフォスファートに依存し,S-ニトロソヘモグロビン (SNO-Hb) レベルと相関していた.
- 赤血球による低酸素血管拡張は,酸素の圧力が低いときにより顕著であり,アロステリックメカニズムを示唆しました.
- CHFの患者は,SNO-Hbと鉄のニトロシルヘモグロビン (HbFeNO) のトランスプルモナリー・グラディエントがコントロールと比較して変化し,心臓指数と逆相関を示した.
結論:
- RBCに結合したNOは,アロステリックメカニズムを通じて低酸素血管拡張を媒介する.
- CHF患者における変化したNO代謝成分のグラデーションは,心機能障害と関連しています.
- ヘモグロビンは,低酸素組織へのNOの輸送を促進し,これはCHFで潜在的に制御不能なプロセスです.
関連する概念動画
Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...


